Editorial: Unraveling Neuroprotective and Neurodegenerative Signals in Neurodegeneration.
作者信息
Vega Irving E, Collier Timothy J
机构信息
Department of Translational Science and Molecular Medicine, College of Human Medicine, Michigan State University Grand Rapids, MI, USA.
出版信息
Front Neurosci. 2016 Jul 13;10:328. doi: 10.3389/fnins.2016.00328. eCollection 2016.
Abstract
摘要
相似文献
1
Editorial: Unraveling Neuroprotective and Neurodegenerative Signals in Neurodegeneration.社论：解析神经退行性变中的神经保护和神经退行性信号
Front Neurosci. 2016 Jul 13;10:328. doi: 10.3389/fnins.2016.00328. eCollection 2016.
2
New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases.新的药物治疗在阿尔茨海默病和帕金森病中显示出神经保护作用。
Neural Regen Res. 2014 Nov 1;9(21):1870-3. doi: 10.4103/1673-5374.145342.
3
Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration.Vps41 介导的神经保护在阿尔茨海默病和帕金森病神经退行性模型中的不同功能作用。
Hum Mol Genet. 2018 Dec 15;27(24):4176-4193. doi: 10.1093/hmg/ddy308.
4
Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease.开灯以阻止神经退行性变：近红外光疗法在阿尔茨海默病和帕金森病中的潜力
Front Neurosci. 2016 Jan 11;9:500. doi: 10.3389/fnins.2015.00500. eCollection 2015.
5
Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease.通过烟碱型乙酰胆碱受体实现的神经保护作用：烟碱型乙酰胆碱受体在阿尔茨海默病和帕金森病等神经退行性疾病中的作用。
Front Biosci. 2008 Jan 1;13:492-504. doi: 10.2741/2695.
6
Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review.探索天然和合成神经保护类固醇治疗神经退行性疾病的潜力：文献综述。
Med Res Rev. 2018 Jul;38(4):1126-1158. doi: 10.1002/med.21458. Epub 2017 Jul 11.
7
Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models.新型双重 GLP-1/GIP 受体激动剂在阿尔茨海默病和帕金森病模型中显示出神经保护作用。
Neuropharmacology. 2018 Jul 1;136(Pt B):251-259. doi: 10.1016/j.neuropharm.2018.01.040. Epub 2018 Jan 31.
8
Glycation in Parkinson's disease and Alzheimer's disease.帕金森病和阿尔茨海默病中的糖基化作用。
Mov Disord. 2016 Jun;31(6):782-90. doi: 10.1002/mds.26566. Epub 2016 Mar 4.
9
Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease.社论：阿尔茨海默病和帕金森病的疾病修饰靶点及策略
Front Aging Neurosci. 2023 Jul 14;15:1247256. doi: 10.3389/fnagi.2023.1247256. eCollection 2023.
10
Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.甲基黄嘌呤和腺苷受体对神经退行性变的影响：人体及实验研究
Handb Exp Pharmacol. 2011(200):267-310. doi: 10.1007/978-3-642-13443-2_10.
引用本文的文献
1
Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.在神经tau 病变小鼠模型和阿尔茨海默病中，ezrin 的表达在疾病进展过程中增加。
Curr Alzheimer Res. 2018;15(12):1086-1095. doi: 10.2174/1567205015666180813152043.
2
A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases.在大鼠模型中单次接触 BMAA 可产生与神经退行性疾病一致的神经病理学变化。
Toxins (Basel). 2017 Dec 29;10(1):22. doi: 10.3390/toxins10010022.
Zotero 插件